SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003221
Filing Date
2022-03-09
Accepted
2022-03-09 16:03:24
Documents
12
Period of Report
2022-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enta-20220303.htm   iXBRL 8-K 51272
  Complete submission text file 0000950170-22-003221.txt   164454

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT enta-20220303_lab.xml EX-101.LAB 12890
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT enta-20220303.xsd EX-101.SCH 2489
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT enta-20220303_pre.xml EX-101.PRE 9541
6 EXTRACTED XBRL INSTANCE DOCUMENT enta-20220303_htm.xml XML 4531
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 22725368
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences